Celiac Disease Study

Celiac Disease Study

Information About This Study:

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide for Relief of Persistent Symptoms in Patients with Celiac Disease on a Gluten Free Diet.

Study Number:

CeD-LA-3001

Indication:

Celiac Disease

Enrolling Now!

Please call Allegiance Research Specialists to see if you qualify: 414-727-8131.